Basic information Description References Safety Related Supplier
ChemicalBook >  Product Catalog >  Inorganic chemistry >  Inorganic salts >  Phosphide And metal phosphates >  Sodium dihydrogen phosphate dihydrate

Sodium dihydrogen phosphate dihydrate

Basic information Description References Safety Related Supplier
Sodium dihydrogen phosphate dihydrate Basic information
Sodium dihydrogen phosphate dihydrate Chemical Properties
  • Melting point:60 °C
  • Density 1,915 g/cm3
  • storage temp. Store at +5°C to +30°C.
  • solubility H2O: 1 M at 20 °C, clear, colorless
  • form Solid
  • color White
  • PH4.0-4.5 (25℃, 50mg/mL in H2O)
  • Water Solubility SOLUBLE
  • Sensitive Hygroscopic
  • λmaxλ: 260 nm Amax: 0.085
    λ: 280 nm Amax: 0.070
  • Merck 14,8660
  • Stability:Stable.
  • InChIKeyVBJGJHBYWREJQD-UHFFFAOYSA-M
  • CAS DataBase Reference13472-35-0(CAS DataBase Reference)
Safety Information
  • Hazard Codes Xi
  • Risk Statements 36-36/37/38
  • Safety Statements 39-26-24/25-36
  • WGK Germany 1
  • RTECS WA1900500
  • TSCA Yes
  • HS Code 2835 22 00
  • ToxicityLD50 orally in Rabbit: 8290 mg/kg LD50 dermal Rabbit > 7940 mg/kg
MSDS
Sodium dihydrogen phosphate dihydrate Usage And Synthesis
  • DescriptionSodium Dihydrogen Phosphate occurs as two forms: the crystal form (dihydrate) called Sodium Dihydrogen Phosphate (crystal) and anhydrous form called Sodium Dihydrogen Phosphate (anhydrous)
    It is used as an acidity regulator and sequestrant in foods. It is used as a pH buffer (baking powders, fleet enema solution, electroplating baths, and acid cleaners), emulsifier, laboratory reagent, metal phosphating reagent, and textile dyeing/printing auxiliary. It is also used to treat boiled water and waste waster and to remove halogen from waste gases. Furthermore, it is used as a cattle feed supplement, as nutritional supplement in food, in dentrifice formulations, in vitreous enamel frits, for the synthesis of pharmaceuticals, and as a phosphate source for micro-organisms in effluent treatment.
  • References[1] http://sydney.edu.au
    [2] https://hazmap.nlm.nih.gov
    [3] https://www.chemsupply.com.au
  • Chemical Propertieswhite crystalline solid
  • Chemical PropertiesThe USP 32 states that monobasic sodium phosphate contains one or two molecules of water of hydration or is anhydrous.
    The hydrated forms of monobasic sodium phosphate occur as odorless, colorless or white, slightly deliquescent crystals. The anhydrous form occurs as a white crystalline powder or granules.
  • Production MethodsMonobasic sodium phosphate is prepared by adding phosphoric acid to a hot, concentrated solution of disodium phosphate until the liquid ceases to form a precipitate with barium chloride. This solution is then concentrated and the monobasic sodium phosphate is crystallized.
  • Pharmaceutical ApplicationsMonobasic sodium phosphate is used in a wide variety of pharmaceutical formulations as a buffering agent and as a sequestering agent. Therapeutically, monobasic sodium phosphate is used as a mild saline laxative and in the treatment of hypophosphatemia.
    Monobasic sodium phosphate is also used in food products, for example, in baking powders, and as a dry acidulant and sequestrant.
  • SafetyMonobasic sodium phosphate is widely used as an excipient in parenteral, oral, and topical pharmaceutical formulations.
    Phosphate occurs extensively in the body and is involved in many physiological processes since it is the principal anion of intracellular fluid. Most foods contain adequate amounts of phosphate, making hypophosphatemia virtually unknown except in certain disease states or in patients receiving total parenteral nutrition. Treatment is usually by the oral administration of up to 100 mmol of phosphate daily.
    Approximately two-thirds of ingested phosphate is absorbed from the gastrointestinal tract, virtually all of it being excreted in the urine, and the remainder is excreted in the feces. Excessive administration of phosphate, particularly intravenously, rectally, or in patients with renal failure, can cause hyperphosphatemia that may lead to hypocalcemia or other severe electrolyte imbalances. Adverse effects occur less frequently following oral consumption, although phosphates act as mild saline laxatives when administered orally or rectally (2–4 g of monobasic sodium phosphate in an aqueous solution is used as a laxative). Consequently, gastrointestinal disturbances including diarrhea, nausea, and vomiting may occur following the use of monobasic sodium phosphate as an excipient in oral formulations. However, the level of monobasic sodium phosphate used as an excipient in a pharmaceutical formulation is not usually associated with adverse effects.
    LD50 (rat, IM): 0.25 g/kg(10)
    LD50 (rat, oral): 8.29 g/kg
  • storageMonobasic sodium phosphate is chemically stable, although it is slightly deliquescent. On heating at 100°C, the dihydrate loses all of its water of crystallization. On further heating, it melts with decomposition at 205℃, forming sodium hydrogen pyrophosphate, Na2H2P2O7. At 250℃ it leaves a final residue of sodium metaphosphate, NaPO3.
    Aqueous solutions are stable and may be sterilized by autoclaving.
    Monobasic sodium phosphate should be stored in an airtight container in a cool, dry place.
  • IncompatibilitiesMonobasic sodium phosphate is an acid salt and is therefore generally incompatible with alkaline materials and carbonates; aqueous solutions of monobasic sodium phosphate are acidic and will cause carbonates to effervesce.
    Monobasic sodium phosphate should not be administered concomitantly with aluminum, calcium, or magnesium salts since they bind phosphate and could impair its absorption from the gastrointestinal tract. Interaction between calcium and phosphate, leading to the formation of insoluble calcium phosphate precipitates, is possible in parenteral admixtures.
  • Regulatory StatusGRAS listed. Accepted for use as a food additive in Europe. Included in the FDA Inactive Ingredients Database (injections; infusions; ophthalmic, oral, topical, and vaginal preparations). Included in nonparenteral and parenteral medicines licensed in the UK. Included in the Canadian List of Acceptable Non-medicinal Ingredients.
Sodium dihydrogen phosphate dihydrate Preparation Products And Raw materials
Sodium dihydrogen phosphate dihydrate(13472-35-0)Related Product Information
Sodium dihydrogen phosphate dihydrateSupplierMore
  • Company Name:Spectrum Chemical Manufacturing Corp. Gold
  • Tel:021-67601398,18616765336,QQ:3003443155
  • Email:mkt@spectrumchina.net
  •  
  • Company Name:Shanghai Aladdin Bio-Chem Technology Co.,LTD Gold
  • Tel:021-20337333/400-620-6333
  • Email:sale@aladdin-e.com
  •  
  • Company Name:J & K SCIENTIFIC LTD.
  • Tel:400-666-7788 +86-10-82848833
  • Email:jkinfo@jkchemical.com;market6@jkchemical.com
  •  
  • Company Name:Meryer (Shanghai) Chemical Technology Co., Ltd.
  • Tel:+86-(0)21-61259100(Shanghai) +86-(0)755-86170099(ShenZhen) +86-(0)10-62670440(Beijing)
  • Email:sh@meryer.com
  •  
  • Company Name:INTATRADE GmbH
  • Tel:+49 3493/605464
  • Email:sales@intatrade.de
  •